Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;60(2):164-174.
doi: 10.1007/s12016-020-08795-5.

Cytoskeletal Organization and Cell Polarity in the Pathogenesis of Crohn's Disease

Chengcen Guo  1 , Jun Shen  2
Affiliations
Review

Cytoskeletal Organization and Cell Polarity in the Pathogenesis of Crohn's Disease

Chengcen Guo et al. Clin Rev Allergy Immunol. 2021 Apr.

Abstract

Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) and affects diverse segments of the entire gastrointestinal tract. Although the underlying causes of CD are not completely known, it is believed that disruption of the intestinal barrier and cell polarity may contribute to pathogenesis. The formation of the intestinal epithelial barrier, which is mainly regulated by cytoskeletal modulations, and apico-basal cell polarity are two major and mutually dependent features of the intestinal epithelial layer. As this layer serves as an important barrier between the external environment and the internal milieu, the defect can start an inflammatory cascade by failing to block the entrance of luminal pathogens and lead to CD. In this review, we highlight the factors and impact of intestinal barrier function and cell polarity in the natural history of CD. The discussion in the present review further strengthens the new challenge in facilitating the development of viable pharmacological targets.

Keywords: Adherens junction; Cell polarity; Crohn’s disease; Inflammatory bowel disease; Intestinal barrier; Tight junction.

PubMed Disclaimer

References

    1. Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9(11):799–809. https://doi.org/10.1038/nri2653 - DOI - PubMed
    1. Katz KD, Hollander D, Vadheim CM, McElree C, Delahunty T, Dadufalza VD, Krugliak P, Rotter JI (1989) Intestinal permeability in patients with Crohn’s disease and their healthy relatives. Gastroenterology 97(4):927–931. https://doi.org/10.1016/0016-5085(89)91499-6 - DOI - PubMed
    1. Sandle GI, Higgs N, Crowe P, Marsh MN, Venkatesan S, Peters TJ (1990) Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology 99(1):97–105 - PubMed
    1. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129(2):550–564. https://doi.org/10.1016/j.gastro.2005.05.002 - DOI - PubMed
    1. Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, Ma TY (2014) Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One 9(3):e85345. https://doi.org/10.1371/journal.pone.0085345 - DOI - PubMed - PMC

LinkOut - more resources